Results 281 to 290 of about 1,806,820 (366)

30‐Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable‐Polymer Sirolimus‐Eluting Ultra‐Thin Stent

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background There is limited evidence on the safety and efficacy of biodegradable‐polymer sirolimus‐eluting ultra‐thin stent (BP‐SES) in patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI). Aims This study aims to evaluate the clinical outcomes of HBR patients treated with BP‐SES and ≤ 30‐day dual ...
Andrea Erriquez, David M. Leistner, Valeria Paradies, Rita Pavasini, Matteo Serenelli, Gianni Casella, Simone Biscaglia, Christoph Naber, Gianluca Campo, Pieter C. Smits   +9 more
wiley   +1 more source

Experimental Studies on Myocardial Metabolism in the Coronary Artery Embolisation

, 1959
Toshiaki Kishii
openalex   +2 more sources

Atherosclerosis of the Coronary Arteries — Epidemiological Considerations [PDF]

, 1960
Aubrey Kagan
openalex   +1 more source

The Impact of Underlying Plaque Characteristics Following the Third‐Generation Resorbable Magnesium Scaffold Implantation: An Intravascular OCT Assessment up to 12‐Months

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Third‐generation resorbable magnesium scaffold (RMS) was developed with stronger mechanical properties and thinner struts compared to its predecessor. This study aimed to assess the influence of the OCT‐derived underlying plaque characteristics on in‐scaffold late lumen loss (LLL) in patients treated with RMS up to 12‐months ...
Alp Aytekin, Masaru Seguchi, Erion Xhepa, Michael Haude, Adrian Wlodarczak, René J van der Schaaf, Jan Torzewski, Hector M. Garcia‐Garcia, Ron Waksman, Michael Joner   +9 more
wiley   +1 more source

Trends and Outcomes Following Percutaneous Coronary Intervention in Patients With Myeloproliferative Neoplasms: Insights From National Database

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Myeloproliferative neoplasms (MPN) are associated with an increased cardiovascular risk including acute coronary syndrome. However, there is a lack of comprehensive data regarding the rate of percutaneous coronary intervention (PCI), as well as the in‐hospital characteristics and outcomes for MPN patients.
Song Peng Ang, Jia Ee Chia, Chayakrit Krittanawong, Robert N. Piana, Kwan Lee, Chadi Ayoub, JR Exequiel Pineda, David Song, Debabrata Mukherjee   +8 more
wiley   +1 more source

The International TrifectaTM and EpicTM Valve‐in‐Valve Registry: Insights Into Clinical & Hemodynamic Outcomes

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Little is known about the clinical and hemodynamic outcome of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR) for failed Trifecta surgical aortic bioprotheses. Aims We aimed to compare outcomes of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR into failed TrifectaTM vs.
Matthias Raschpichler, Mohamed Abdel‐Wahab, Nick Curzen, Manuel Wilbring, Christoph Dubois, Kayan Lam, Gloria Faerber, Jana Nagel, Holger Thiele, Michael A. Borger   +9 more
wiley   +1 more source

Impact of Post Percutaneous Coronary Intervention Fractional Flow Reserve on 5‐Year Clinical Outcomes (The FFR SEARCH Study)

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Fractional flow reserve (FFR) following percutaneous coronary intervention (PCI) can be used to evaluate procedural success and to guide stent optimization. Several studies have demonstrated that lower FFR after stent implantation is associated with increased adverse event rates up to 2 years.
Frederik T. W. Groenland, Annemieke C. Ziedses des Plantes, Tara Neleman, Alessandra Scoccia, Jari A. van der Eijk, Kaneshka Masdjedi, Laurens J. C. van Zandvoort, Wijnand K. den Dekker, Jeroen M. Wilschut, Isabella Kardys, Paul Cummins, Roberto Diletti, Nicolas M. Van Mieghem, Joost Daemen   +13 more
wiley   +1 more source

INTERNAL MAMMARY ARTERY IMPLANTATION FOR CORONARY HEART DISEASE

, 1963
W.G. Bigelow, Herbert Basian, George A. Trusler   +2 more
openalex   +1 more source

Impact of Coronary Calcification on Complete Revascularization in Patients With Acute Coronary Syndrome and Multivessel Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary calcification is a well‐known marker of atherosclerotic plaque burden and a determinant of stent under expansion with unfavorable long‐term outcomes. Aims This sub study of the randomized BIOVASC trial aimed to compare immediate complete revascularization (ICR) and staged complete revascularization (SCR) in patients with ...
William Camilleri, Hala Kakar, Jacob J. Elscot, Eric Boersma, Nicolas M. Van Mieghem, Roberto Diletti, Joost Daemen, Elena Ntantou, Jeroen Wilschut, Rutger Jan Nuis, Wijnand K. Den Dekker   +10 more
wiley   +1 more source

Extended Treatment of Severe Coronary Artery Disease

, 1969
Warren D. Johnson, Robert J. Flemma, Derward Lepley, Edwin H. Ellison   +3 more
openalex   +2 more sources